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Abstract
Anxiety is a leading mental health concern among college students. A growing number of
students are presenting with symptoms of generalized anxiety disorder (GAD), which is one of
the most common anxiety disorders. As demands for treatment of this disorder increase,
counseling centers are also facing limited funding for providing such services. The result is that
there is a need to provide more cost effective, and empirically supported approaches to treatment.
Therefore, implementing a program that will allow students to utilize already accessible
technology to teach themselves how to combat anxiety is merited. Virtual reality therapy (VRT),
is one such technology and it has been found to be an effective treatment for GAD and a wide
variety of other mental health disorders. VRT has not been implemented in a college counseling
center for treatment of GAD to this author’s awareness. Therefore, a proposal for utilizing a
VRT in college counseling centers for the treatment of GAD in college students is warranted to
address the noted increasing needs for services. The origins, assessment, and treatment of GAD
are outlined in this project. A brief overview of VRT efficacy and nature therapy is also
reviewed. A novel, 11 session, proposed protocol for utilizing VRT in the treatment of GAD in
college counseling centers is also detailed.
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Section I: Introduction
Statement of the Problem
College students are a rising population, with nearly 20 million students in the US
seeking postsecondary education, which means a growing number of students are in a place to
obtain mental health treatment while attending a university (Xiao et al., 2017). Many mental
disorders have onsets at an early age and college students often face specific environmental
difficulties, which puts them at an increased risk for developing mental health issues (Xiao et al.,
2017). The Center for Collegiate Mental Health (2015) reports that between Fall 2009 and
Spring 2015 student utilization of the counseling center had an average increase of 30 – 40%,
although overall enrollment only increased by 5%, suggesting an increase in the use of
counseling center services.
Recent data suggests that student’s self-reported levels of anxiety continue to increase
(Center for Collegiate Mental Health, 2019). One study reported 61.8% of students who sought
services in a college counseling center in 2018 reported concerns with anxiety, making it the
most common reason for seeking services (Center for Collegiate Mental Health, 2019). More
specifically, 41.5% of the 61.8% of these students with anxiety concerns reported symptoms of
generalized anxiety (Center for Collegiate Mental Health, 2019). With such a significant and
steady increase in anxiety related concerns, there was an increasing realization that college
counseling centers would likely require more resources to support these demands (Xiao et al.,
2017). The status of collegiate mental health has been described as being in “crisis” due to the
rising population of college students, coupled with increased anxiety among these students and a
heavy strain on the resources that counseling centers have been allocated (Xiao et al., 2017).
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Not only are college students facing increasing concerns, college counseling centers are
also facing their own struggles. Since the 1980’s, when counseling centers switched their service
provisions from career counseling to psychotherapy, counseling centers have faced budget
constraints that have limited their ability to provide such services (Gallagher, 2012). Counseling
center services are often provided free of charge and their money comes from Student Health
service fees that accompany tuition, which poses problems with a limited allocated annual
budget, despite increased demands (Gallagher, 2012). Given their restricted budget, counseling
centers often face a lack of personnel resources which would be needed to implement novel
interventions for the treatment of disorders, such as GAD.
The purpose of this project is to introduce a novel protocol for treating GAD in college
students, receiving treatment in a counseling center setting. Specifically, this project proposes the
integration of virtual reality therapy (VRT) with traditional intervention methods. This project
will review the effectiveness of VRT in treating GAD and how it may be adapted for this
purpose as a cost efficient treatment in college counseling centers. It is hypothesized that this
proposed VRT program may increase treatment adherence and outcomes. It is also hypothesized
that students may be more likely to utilize such an intervention as it coincides with the interest in
technology and its application for younger generations.
Significance of Issue
An alarming 86% of all college students diagnosed with a mental illness, end up dropping
out of college prior to graduating (Salzer, 2012). The average college withdrawal rate for
students who do not have a mental illness is 45%, which highlights the detrimental effects that
mental illness can have on college success (Salzer, 2012). University administrations have
become increasingly focused on student retention rates as they represent student success within
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the university, thus, student mental health has become a part of the focus in increasing retention
rates (Scofield et al., 2017). It has been documented within research that higher retention rates
were present in students who received counseling center treatment than students who did not
receive such services (Scofield et al., 2017). Specifically, 75% of students being seen at
counseling centers registered for the next semester of classes, when only 68% of the overall
student population registered for the following semester (Scofield et al., 2017).
Symptoms that accompany many mental illnesses that may hinder a student’s ability to
engage on campus include concentration, motivation, and social interactions (Salzer, 2012). A
significant 70% of participants in one particular study on retention reported that their personal
issues negatively impacted their performance in academics (Lee, Olson, Locke, Michelson &
Odes, 2009). A promising 60.7% of those students indicated that they believed their counseling
center services helped improve their academic performance (Lee et al., 2009).
There is a significant amount of research that demonstrates the positive effect counseling
centers have on college students’ wellbeing, with demonstrated increases in social and emotional
wellness (Scofield et al., 2017). Research has also revealed that positive social and emotional
health is correlated with improved academic performance (Scofield et al., 2017). Regardless of
the demonstration of positive impact from services received at counseling centers, funding is still
often insufficient despite reported increase in demands yearly, with use of counseling centers
growing five times faster than university enrollment (Scofield et al., 2017). This makes it more
difficult for counseling centers to meet the needs of students with mental illness and requires
personnel to look for novel interventions that can address widely reported concerns, such as
generalized anxiety disorder.
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Purpose
The purpose of this project is to propose a novel VRT intervention for the treatment of GAD
in college counseling centers. Particularly, this VR component would work as an adjunct to
traditional therapies, like cognitive behavioral therapy (CBT) and mindfulness-based meditation
(MBM), for treating GAD in counseling centers within university communities. This VRT
component will utilize guided meditations and diaphragmatic breathing exercises to help
students build relaxation skills, and reduce overall levels of arousal, which is a key component in
treating GAD symptoms.
Although there is evidence that VRT can be effective in treating GAD, there is little to no
documentation of it being formally implemented in a counseling center setting to address GAD
in students. Given the prevalence of anxiety cases seen in college counseling centers, as well as
the lack of funding available to meet such high demands for treating it, VR could provide a costeffective addition to services. VRT has the potential to help counseling centers increase retention
rates and increase students’ sense of well-being, which has been well documented to affect
academic performance.
The proposed protocol in section III of this paper is proposed to address anxiety related
symptoms found in students who meet the criteria for GAD and is designed to be implemented in
a college counseling center. Utilizing VRT therapy may be an effective adjunct to therapy for
university students who may be more motivated to participate due to interest in new technology.
It is hypothesized that employing a VRT adjunct to therapy will reduce symptoms associated
with GAD in college students over the course of 11 sessions.
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Section II: Literature Review
Etiology of Generalized Anxiety Disorder
There is a wealth of research on the etiology of GAD which results from a combination
of biological, psychological, and environmental factors, which are highlighted below. Anxiety
and fear related emotional responses are critical for humans to survive (Parsons & Rizzo, 2008).
However, when these responses become excessive, they can have detrimental effects on one’s
functioning (Schienle, Hettema, Cáceda, & Nemeroff, 2011). Thus, the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition outlines the criteria for GAD which is shown in Figure
1 (American Psychiatric Association, 2013).

A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not
for at least 6 months, about a number of events or activities (such as work or school
performance).
B. The individual finds it difficult to control the worry.
C. The anxiety and worry are associated with three (or more) of the following six symptoms
(with at least some symptoms having been present for more days than not for the past
6 months):
1.
2.
3.
4.
5.
6.

Restlessness or feeling keyed up or on edge.
Being easily fatigued.
Difficulty concentrating or mind going blank.
Irritability.
Muscle tension.
Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying
sleep).
B. The anxiety, worry, or physical symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of functioning.
C. The disturbance is not attributable to the physiological effects of a substance (e.g., a drug
of abuse, a medication) or another medical condition (e.g., hyperthyroidism).
D. The disturbance is not better explained by another mental disorder (e.g., anxiety or worry
about having panic attacks in panic disorder, negative evaluation in social anxiety
disorder [social phobia], contamination or other obsessions in obsessive-compulsive
disorder, separation from attachment figures in separation anxiety disorder, reminders of
traumatic events in posttraumatic stress disorder, gaining weight in anorexia nervosa,
physical complaints in somatic symptom disorder, perceived appearance flaws in body
dysmorphic disorder, having a serious illness in illness anxiety disorder, or the content of
delusional beliefs in schizophrenia or delusional disorder).
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Figure I: Generalized Anxiety Disorder Diagnostic Criteria. Diagnostic and Statistical Manual of Mental
Disorders (5th ed.). Copyright 2013 by the American Psychiatric Association.

Biological Factors. It is important that we consider the genetic and neural mechanisms
relevant in the development of GAD. It has been well documented that the amygdala, a limbic
structure that processes emotional situations, is central to fear responses in both humans and
animals (Kim et al., 2011). MRI studies have demonstrated that subjects who are diagnosed with
GAD have significantly larger amygdala volumes (De Bellis, 2000). Furthermore, people with
anxious or fearful traits demonstrate increased amygdala activation (Beesdo et al., 2009). Foell,
Palumbo, Yancey, Vizueta, Demirakca and Patrick (2019) conducted a study of twins using MRI
technology that demonstrated that participants with a high threat sensitivity also have less
amounts of amygdala gray matter. This suggests that the volume of gray matter in the brain may
be of use as a biomarker for anxiety disorders (Foell et al., 2019).
There is indication that the right dorsal medial prefrontal cortex (DMPFC) also plays a
role in the development of GAD, as studies have found the DMPFC has a larger volume in
individuals with GAD and is correlated with high scores on the Penn State Worry Questionnaire
(PSWQ) (Hettema et al., 2012). The DMPFC has also been found to be associated with cognitive
emotion regulation and outcome anticipation, thus altered activation in this region may
contribute to affect regulation issues found in individuals with GAD (Schienle et al., 2011).
Paulesu et al. (2012) conducted a functional magnetic resonance imaging (fMRI) study in which
he observed the activation in the DMPFC and amygdala in both GAD patients and control
patients. This study revealed that both groups demonstrated activation in those areas during the
“worrying” activity, but the group who was diagnosed with GAD had different postworry states,
where the activation continued, suggesting that GAD patients have difficulty stopping their
worrying process (Paulesu et al., 2012). Another key issue in patients with GAD is their
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experiencing of anticipatory anxiety, and studies have demonstrated that patients with GAD have
more activation in the amygdala during anticipatory intervals than healthy controls (Schienle et
al., 2011).
There is also some evidence that the hypothalamic-pituitary-adrenal (HPA) axis is related
to the etiology of GAD, particularly genetic variants in the pituitary adenylate cyclase-activating
peptide (PACAP) and PACAP-type-I-receptor (PAC1) genes (Cooper, Narasimhan, Rickels, &
Lohoff, 2013). The PACAP and PAC1 genes affect the activity in the HPA axis and are believed
to modulate anxiety behaviors (Cooper et al., 2013). Specifically, the variant rs2856966
(Asp54Gly) is associated with better treatment response to SSNRIs in patients with GAD
(Cooper et al., 2013).
In addition to neuroanatomical differences in patients with GAD, there is evidence that
neurotransmitter dysregulation plays a role in the development of GAD as well. These
abnormalities range from decreased inhibitory neurotransmission to increased excitatory
neurotransmission (Schienle et al., 2011). The neurotransmitter gamma-aminobutyric acid
(GABA) has been demonstrated to impact anxiety disorders and GABA-A receptor
downregulation has been documented in individuals with GAD (Schienle et al., 2011).
Another key neurotransmitter involved in the regulation of anxiety is serotonin (5-HT),
although research is mixed on whether 5-HT increases or decreases anxiety (Graeff, Viana, &
Mora, 1997). Research has demonstrated that lower levels of serotonin were found in the
cerebrospinal fluid of patients with GAD in comparison to the control group (Schienle et al.,
2011). Similarly, researchers found less paroxetine platelet binding in individuals with GAD,
which means they had less serotonin transporter binding sites (Schienle et al., 2011).
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Antidepressant medication treats GAD by improving 5-HT neurotransmission, however,
benzodiazepine anxiolytics treat GAD by decreasing 5-HT release (Graeff et al., 1997).
Another commonly studied system related to internalizing disorders is the dopaminergic
system. The gene related to dopamine transportation, DAT1, regulates the amount of dopamine
available in the brain and has been identified as being associated with behavioral phenotypes
(Rowe et al., 1998). Moreover, Rowe et al. (1998) found that GAD was associated with a greater
number of DAT1 10-repeat allele.
There is also some evidence that cortisol levels may be related to GAD (Schienle et al.,
2011). Cortisol is a hormone that is released in response to stressful events (Elnazer & Baldwin,
2014). Individuals with Cushing’s disease, a disorder in which the body produces too much
cortisol, have high rates of GAD and when these individuals get their hypercortisolism treated
they demonstrate a decrease in anxiety disorders (Elnazer & Baldwin, 2014). However, other
evidence suggests that individuals with GAD actually demonstrate significantly lower levels of
cortisol concentrations in their hair follicles and demonstrate hypocortisolism rather than
hypercortisolism (Elnazer & Baldwin, 2014). Escitalopram, an SSRI antidepressant medication,
has also been shown to be associated with normal salivary cortisol levels (Schienle et al., 2011)
in elderly individuals with GAD whenever they previously had elevated cortisol levels (Elnazer
& Baldwin, 2014). Furthermore, one study found that the administration of intravenous
diazepam, a medication commonly used in the treatment of GAD, demonstrated a decrease in
cortisol levels (Elnazer & Baldwin, 2014). Another study administered cognitive therapy to 24
patients with GAD and found that after treatment they demonstrated a significant decline in
plasma cortisol levels (Elnazer & Baldwin, 2014). However, these results should be interpreted
with caution as other medications used to treat individuals with GAD, such as buspirone,

VIRTUAL REALITY THERAPY FOR GAD

15

demonstrated no changes in plasma levels of cortisol and there is mixed evidence regarding
cortisol levels prior to treatment in patients with GAD (Elnazer & Baldwin, 2014).
In addition to neuroanatomical structures and neurotransmitter dysregulation, there are
genetic risks for GAD as well. There is high concordance for GAD among monozygotic (MZ)
twins, who are identical genetically, which suggests this disorder has a genetic factor (Schienle et
al., 2011). Twin studies have also supported family study results that familial aggregation is
related to GAD (Schienle et al., 2011). However, only 15% to 30% of heritability for GAD can
be determined given the uncontrolled variable of common family environments in the role of
familial aggregation (Schienle et al., 2011). The personality construct of neuroticism has also
been documented to be related to the development of GAD and neuroticism has a small but
significant genetic correlation (Schienle et al., 2011). Mackintosh, Gatz, Wetherell, and Pedersen
(2006) discussed how high levels of the personality construct neuroticism is correlated with
increased levels of worry, and neuroticism is moderately heritable, with 40% to 60% heritability
estimates. A twin study evaluating the bivariate relationship involving genes associated with
GAD and neuroticism had a genetic correlation of .57, suggesting that GAD and neuroticism do
share some genetic influences (Mackintosh et al., 2006).
Psychological Factors. There are a variety of psychological factors that may play into
the development of GAD. Whenever a human identifies something they perceive as threatening
cognitive, affective, physiological, and behavioral systems are activated to ensure their safety
(Ouimet, Gawronski, & Dozois, 2009). The development of GAD occurs when these systems
over-activate, and research demonstrates that cognitive factors may play a role in how we
process threat-relevant material (Ouimet et al., 2009). For example, a significant amount of
research suggests that individuals with anxiety pay more attention to threatening stimuli and find
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it more difficult to disengage from a stimulus that they perceive as threatening (Ouimet et al.,
2009). Contrastingly, some research indicates individuals with anxiety disorders are more likely
to avoid the threatening stimuli, and such avoidance positively reinforces their fear (Ouimet et
al., 2009). GAD differs from other anxiety disorders in that their worry is usually constant and
unspecific, and involves interacting attentional, conceptual, imaginal, physiological, affective,
and behavioral systems that respond to a continually changing environment (Navarro-Haro et al.,
2019).
Another important cognitive factor in the perception of threats is how an individual
interprets the threat. Ouimet et al. (2009) reported that individuals with anxiety are more likely to
interpret neutral stimuli as negative or threatening compared to control participants. Individuals
with anxiety disorders are also found to have less proficient abilities in cognitive control, which
is important in managing a negative emotional state (Schienle et al., 2011). These results suggest
that individuals with GAD demonstrate a cognitive vulnerability to anxiety. Ouimet et al. (2009)
found that the higher number of threat-related cognitive associations an individual has, the more
likely they are to develop an anxiety disorder.
Additionally, cognitive reappraisal, in which one re-evaluates their thinking about a
future event to prevent negative emotional impact, is associated with anxiety symptoms in adults
(Marganska, Gallagher, & Miranda, 2013). Furthermore, expressive suppression, which is the
inhibition of an active emotional response, is also associated with anxiety symptoms and higher
negative affect (Marganska et al., 2013). A meta-analysis reported that three cognitive regulatory
strategies were strongly associated to anxiety disorders including rumination, reappraisal
difficulties, and emotional avoidance (Marganska et al., 2013). Individuals who have
hyperreactivity in their amygdala to relevant cues demonstrate difficulties regulating their
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negative affect, which is associated with anxious traits (Schienle et al., 2011). Additionally, the
well-researched personality characteristic of neuroticism has been shown to impact how much
someone worries, and high scores in neuroticism have been shown to be significantly associated
with a GAD diagnosis (Mackintosh et al., 2006). One study found that college students with
GAD are less accepting of their emotions and believe themselves to be less capable of regulating
such emotions compared to control participants (Marganska et al., 2013).
Literature suggests that individuals with GAD are more likely to make logical cognitive
errors including unrealistic perceptions of physical and/or psychological threats and are more
likely to hold core cognitive beliefs that the world is a dangerous place (Cassidy, LichtensteinPhelps, Sibrava, Thomas, & Borkovec, 2009). Individuals with GAD are also more likely to
overestimate the likelihood and intensity of feared events, as well as undervaluing their own
ability to cope with such events (Cassidy et al., 2009).
One study demonstrated that people with GAD experience unusually intense negative
emotions and do not use adaptive emotional regulation skills, instead they rely on a less adaptive
strategy such as worrying to avoid distress (Cassidy et al., 2009). Individuals with GAD often
avoid experiencing distress and negative emotions and do so by distracting themselves with
abstract conceptual thoughts of worry (Cassidy et al., 2009). Another key risk factor for
developing GAD is the inability to tolerate uncertainty, and this characteristic is thought to be
reinforced by positive beliefs about worry, negative problem orientation, and cognitive
avoidance (Hebert & Dugas, 2019).
Environmental Factors. Early environmental factors also play a role in the etiology of
GAD. Insecure attachment to caregivers has been shown to be correlated with anxiety symptoms
later in life (Marganska et al., 2013). Specifically, anxious attachment styles, are show to be
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associated with GAD diagnoses later in life (Marganska et al., 2013) Attachment plays an
important role in the development of the fear system as a child seeks protection from their
attachment figure, and the availability and responsiveness of their caregiver plays a role in
reducing the child’s fearfulness (Cassidy et al., 2009). Insecurity within attachment was also
positively correlated with emotion dysregulation, suggesting this may play a role in the
development of anxiety disorders (Marganska et al., 2013). Fearful avoidant and preoccupied
attachment styles were found to have the strongest correlations with GAD symptoms (Marganska
et al., 2013). These attachment styles are documented to result in hyperactivated emotional
regulation strategies, which involve amplified monitoring of threats to one’s self, which is
relevant to individuals with GAD who have a tendency to have attentional bias to threats
(Marganska et al., 2013).
Contrastingly, secure attachment styles are negatively correlated with GAD symptoms
(Marganska et al., 2013). Furthermore, a longitudinal study demonstrated that adolescents who
had high frequency of GAD symptoms perceived that they had a lower quality attachment
relationship with both of their parents (van Eijck, Branje, Hale, & Meeus, 2012). Additionally,
adolescents who viewed their attachment relationship with their father as low quality were more
likely to have higher levels of GAD symptoms later on (van Eijck et al., 2012).
Other environmental factors may play a role in the etiology and maintenance of GAD,
including parental loss before the age of 16 and exposure to traumatic events (Cassidy et al.,
2009). Furthermore, research shows that GAD occurs within families but lacks a strong genetic
component, which suggests that family social relationships may be related to the etiology of
GAD (Cassidy et al., 2009). For example, children who experienced role reversal, in which they
became the caregiver for their parent, demonstrated high rates of GAD in adulthood, likely
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because they lacked a secure base in childhood, could not rely on their parent for care, and in
turn had to provide care for the incompetent parent (Cassidy et al., 2009). Research also found
that low maternal love and high maternal rejection/neglect were positively associated with GAD
rates (Cassidy et al., 2009). It is hypothesized that these results are due to these experiences
leading the child to use cognitive and emotional mechanisms that are avoidant of the painful
feelings that occur with such negative maternal treatment (Cassidy et al., 2009). Further research
has noted that college students who have higher symptoms of worry and diagnoses of GAD were
more likely to perceive themselves as alienated from maternal figures and their peers (Viana &
Rabian, 2008). This suggests there is an interpersonal component to the etiology of GAD. It was
also found that those who worry put greater focus on interoceptive cues and bodily symptoms,
which may impact relational attachment (Viana & Rabian, 2008). Feeling alienated from one’s
support system or caregiver may be related to higher levels of psychopathology (Viana &
Rabian, 2008).
An additional environmental factor that may play a role in the etiology of GAD is
exposure to trauma. GAD has high comorbidity levels with Posttraumatic Stress Disorder
(PTSD) diagnoses, with a range of 11.1% to 31.6% in trauma-exposed patients (Price & van
Stolk-Cooke, 2015). Exposure to traumatic events may trigger genetic predispositions to
psychiatric conditions, per the diathesis-stress model of psychopathology. The diathesis-stress
model refers to theory that humans can carry genetically inherited risks for mental illnesses, and
that stressful life events can result in the expression of such genes (Patten, 2013). Thus, someone
who inherits a genetic predisposition to anxiety may see that gene expressed following a
traumatic life event.
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Assessing Generalized Anxiety Disorder
It is important that we understand how to properly assess and diagnose GAD. Assessment
procedures often involve a comprehensive psychological evaluation that includes both specific
assessment measures, known as narrowband instruments, as well as broadband assessment
instruments to evaluate overall psychopathology. The assessment procedure should also always
include deliverance of informed consent and a clinical interview.
Narrowband Instruments. Narrowband instruments are assessments that are often brief
in length and assess specific psychological constructs, such as generalized anxiety. Narrowband
instruments are important in gathering information on specific diagnostic rule outs. Following
are several narrowband instruments that are commonly used to assess GAD.
Generalized Anxiety Disorder Questionnaire (GAD-7). The GAD-7 is a 7 item selfreport scale that was created by Spitzer, Kroenke, Williams, Williams, and Löwe (2006) to
screen clients for the presence and severity of GAD defining symptoms. This measure is time
efficient and easily scored, so it is frequently used in short term care settings (Rutter & Brown,
2017). Research has demonstrated that the GAD-7 has strong reliability and psychometric
backing (Rutter & Brown, 2017). Additionally, the GAD-7 has been found to be a valid measure
of generalized anxiety symptoms with strong sensitivity (.83) as well as strong convergent
validity and internal consistency (Rutter & Brown, 2017).
Hamilton Anxiety Rating Scale (HAM-A). The Hamilton Anxiety Scale is a clinician
administered measure of the severity of perceived anxiety symptoms that was developed by
Hamilton in 1959. The scale assesses 14 symptom features including both psychological and
somatic symptoms (Thompson, 2015). The scale has sufficient reliability and validity, with both
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good inter-rater reliability and test-retest reliability (Thompson, 2015). The scale takes
approximately 12 – 15 minutes to administer (Thompson, 2015).
Penn State Worry Questionnaire (PSWQ). Meyer, Miller, Metzger, and Borkovec
(1990) designed the PSWQ to assess a client’s habitual worrying and determine whether it is
pervasive, excessive, and/or uncontrollable, all key determining factors in diagnosing GAD.
Meyer et al. (1990) reported strong internal consistency (α= .91) in the PSWQ and Rutter and
Brown (2017) found strong discriminant and convergent validity in this measure, showing that
the PSWQ is an acceptable measure to assess symptoms related to GAD.
Beck Anxiety Inventory (BAI). The BAI is a commonly used measure of symptoms of
anxiety that consists of 21 self-report items (Beck & Steer, 1993). The BAI has strong internal
consistency with a Cronbach’s alpha of .92 (Beck, Epstein, Brown, & Steer, 1988). It also has
good test-retest reliably of one week of .75 (Beck et al., 1988). Muntingh et al. (2011) found that
the BAI is a useful indicator of the severity of anxiety symptoms in patients with anxiety
disorders.
Counseling Center Assessment of Psychological Symptoms (CCAPS). The CCAPS is an
assessment measure that is specifically designed for use in college counseling centers as a way to
screen for psychological symptoms and/or to track progress in addressing psychological
symptoms. The longer version of the CCAPS, the CCAPS-62 (Locke et al., 2011), is commonly
used during the initial contact with a student to assess for target areas, as well as during the final
contact to provide a comprehensive assessment of treatment outcomes. The shorter version, the
CCAPS-34 (Locke et al., 2012) is commonly used to track progress session by session in college
counseling centers.
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The CCAPS-62 is a 62 item self-report measure that is specifically designed to assess
psychological symptoms in college students across nine subscales. The subscales assess for
symptoms related to generalized anxiety, social anxiety, depression, academic distress, eating
concerns, family distress, hostility, substance use, and overall distress (Locke et al., 2011). The
CCAPS-62 requires an 8.7 grade reading level and generally takes 7 – 10 minutes to complete
(Locke et al., 2011).
The CCAPS-34 is a 34 item self-report measure that is designed to be a brief version of
the CCAPS-62. This assessment measure has eight subscales compared to the nine subscales of
the CCAPS-62. The CCAPS-34 utilizes the same items as the CCAPS-62 but does not assess for
family distress. Additionally, the CCAPS-34 specifically assesses for alcohol use instead of
overall substance use like the CCAPS-62 does. The reading level for the CCAPS-34 is slightly
higher, with a grade nine level required (Locke et al., 2012). This measure only takes on average
2 – 3 minutes to complete, which makes it a valuable measure to track progress quickly
throughout treatment.
Both the CCAPs-62 and the CCAPS-34 will be utilized to assess symptoms of GAD for
the proposed VRT program outlined in section III of this paper. Specifically, the generalized
anxiety subscale on the CCAPS measures will be used to track student progress throughout the
proposed program and to assess for efficacy of treatment. The generalized anxiety subscale on
the CCAPS-62 has strong internal consistency with a Cronbach’s alpha of .84 (Locke et al.,
2011). The CCAPS-34 also had similarly strong internal consistency with a Cronbach’s alpha of
.83 (Locke et al., 2012).
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Broadband Instruments. Broadband instruments help a clinician get a full picture of a
wide range of personality and psychopathology. Descriptions of more commonly used broadband
instruments include the ones noted below.
Personality Assessment Inventory (PAI). The PAI is a measure of personality and
psychopathology which has a specific scale that captures generalized anxiety symptoms (Morey,
1991). This specific scale, ANX, also has three subscales, ANX-C, ANX-A, and ANX-P, which
are used to assess cognitive, affective, and physiological symptoms of anxiety (Morey, 1991).
Minnesota Multiphasic Personality Inventory – 2 – Restructured Form (MMPI-2-RF).
The MMPI-2-RF is another broadband psychological measure of personality and
psychopathology (Ben-Porath, 2012). The MMPI-2-RF includes a specific scale, RC7, which
evaluates dysfunctional negative emotions, including anxiety (Ben-Porath, 2012). Other relevant
subscales include the internalizing subscale AXY, which assesses for general anxiety symptoms
(Ben-Porath, 2012). Other related constructs on the MMPI-2-RF include the Personality
Psychopathology Five (PSY-5) Scales, which measures a specific personality construct, NEGE-r,
Negative Emotionality/Neuroticism, which is associated with symptoms of anxiety (Ben-Porath,
2012).
Evidence Based Practices
Once a diagnosis of GAD has been assessed, it is critical that clinicians know the types of
evidence-based treatments available to provide the best care possible. It is also important to
consider the best utilized practices currently available and how this novel intervention program
can build upon this research. Given GAD symptoms often involve the activation of several
biological systems, outlined below are some of the most common physical, behavioral, and
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cognitive targeted strategies that are currently used to treat GAD symptoms. Both physical and
psychological interventions for the treatment of GAD are reviewed below.
Physical strategies. GAD often results in high levels of arousal over a long period of
time. Due to the physical symptoms that often accompany GAD, interventions that target the
physical responses of anxiety are important.
Diaphragmatic breathing. Research has demonstrated that feelings of anxiety and
chronic hyperventilation are positively associated, likely due to concurrent abdominal bracing
that occurs in the fight-flight response, as well as the inhibition of the exhalation phase of
respiration (Peper & MacHose, 1993). Feelings of anxiety also cause people to breathe in a
shallower manner, and respiration dysfunction ma increase the physical and emotional
complaints related to anxiety (Peper & MacHose, 1993). Thus, it is important that patients
become aware of this and learn techniques to reduce this response. Further research has
demonstrated that the inhibition of exhalation significantly increases an individual’s perception
of their sense of anxiety, while inducing slow diaphragmatic breathing significantly decreases
their sense of anxiety (Peper & MacHose, 1993).
Diaphragmatic breathing relaxation exercises are evidence-based treatments that decrease
both the perceptions and symptoms of anxiety (Chen, Huang, Chien, & Cheng, 2017). This
treatment is advantageous due to its natural basis, safety, cost-effectiveness, and ease of both
learning and practicing the technique (Chen et al., 2017). Diaphragmatic breathing is conducted
by contracting the diaphragm muscle, pushing air downward into the body which lengthens the
diaphragm and increases breathing efficiency and exhalation (Chen et al., 2017). This process
also relaxes and stabilizes the autonomic nervous system, which is important in addressing
physical anxiety symptoms including: pressure and/or constriction of the chest, dyspnea, shallow
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breathing, hyperventilation, increased respiratory rates, tachycardia, palpitations, and increased
peripheral blood flow (Chen et al., 2017). Whenever the sympathetic nervous system is activated
due to anxiety, diaphragmatic breathing can stimulate the parasympathetic nervous system,
which reduces anxiety levels, by increasing carbon dioxide levels in the blood (Chen et al.,
2017). Diaphragmatic breathing also induces relaxation, in which neuromuscular activity is
decreased which decreases proprioceptive input into the hypothalamus (Mizrahi et al., 2012).
Diaphragmatic breathing has also been well documented to increase not only relaxation but
concentration and body temperature, as well as stabilize heartbeat and blood pressure (Chen et
al., 2017). Chen et al. (2017) found that diaphragmatic breathing as a relaxation technique is
positively associated with reduced levels of anxiety, as well as skin conductivity, heart rate, and
breathing rate.
There is even evidence that diaphragmatic breathing can increase treatment outcomes in
virtual reality exposure therapy (VRET) (Shiban et al., 2017). Shiban et al. (2017) conducted a
study that demonstrated that VRET was more effective when participants were taught
diaphragmatic breathing as a coping skill, as it led to participants having less fear and lower
physiological arousal during the exposures.
Pharmacology Interventions. An additional physical intervention that clients may opt to
use is a pharmacological approach to treating their GAD. SSRIs (selective serotonin-reuptake
inhibitors), SNRIs (serotonin/norepinephrine-reuptake inhibitors), buspirone, pregabalin, and
BZDs (benzodiazepines) have been found to be most effective in treating the symptoms of GAD
and are reviewed below (Chen, Huang, Hsu, Ouyang, & Lin, 2019).
Comorbid mood and anxiety disorders are common in individuals with GAD, and all of
these related disorders are responsive to particular antidepressant treatments (Schienle et al.,
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2011). SSRIs and SNRIs are shown to be effective in reducing the symptoms of GAD, while the
SSRI paroxetine is the most commonly studied medicine for GAD symptoms, as it decreases
symptoms associated with harm avoidance (Schienle et al., 2011). SSRIs are usually the first line
of treatment (Goodman, 2004) and also demonstrate a significant reduction in negative affect,
which includes negative emotions such as anxiety (Knutson et al., 1998). He et al. (2019)
conducted a network meta-analysis that found that venlafaxine (SNRI), escitalopram (SSRI), and
duloxetine (SNRI) were more effective than vortioxetine, and that although sertraline (SSRI) is
well tolerated it is not as effective as venlafaxine (SNRI), escitalopram (SSRI), or duloxetine
(SNRI). They found that all SSRI and SNRI drugs in the study were significantly more effective
than the placebos (He et al., 2019). SSRIs and SNRIs are generally well tolerated but clinicians
should use caution in noting the bleeding risks in using SSRIs (Chen et al., 2019).
Another well documented treatment of GAD is using medications that increase GABA
within the synapse, and these include BZDs and barbiturates (Schienle et al., 2011). These
GABA receptor medications help individuals deal with GAD related symptoms such as
worrying, hypervigilance, and psychomotor agitation (Schienle et al., 2011). It is recommended
that medication use be continued for a minimum of six months to a year to prevent relapse in
treating GAD (Tomasi et al., 2019). Clinicians should exercise caution in the use of BZDs as
they are associated with long-term dependence and are not recommended as a first-line treatment
but may provide a good short-term adjunct to other psychiatric medications in the time it takes
for SSRIs and SNRIs to begin taking effect (Chen et al., 2019). Medications that work on GABA
receptors are also associated with adverse side effects, lack of long-term efficacy, and addiction
problems (Goodman, 2004).
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Buspirone, a psychiatric medication used to treat GAD from the azapirones class of
drugs, is a non-BZD anxiolytic drug and a partial serotonin 5-HT1A receptor agonist (Chen et
al., 2019). Benefits of using this medication include shorter onset of action, less side effects, and
less potential for abuse or dependence (Chen et al., 2019). Buspirone also does not have any
sedating effects like BZDS, however, it should be noted that it does often require administration
three times daily, compared to typical once daily administration of SSRIs or SNRIs (Goodman,
2004). Anticonvulsant drugs may also be used if a person does not tolerate SSRIs or SNRIs well,
and pregabalin is the most commonly used medication in this class for treatment of GAD (Chen
et al., 2019). This drug is advantageous because it has early onset anxiolytic effects with
relatively minimal side effects (Chen et al., 2019). Finally, trazodone, tricyclic antidepressants,
and monoamine oxidase inhibitor phenelzine also demonstrate anxiolytic properties but are
considered only if the above medications do not work due to adverse side effects (Goodman,
2004).
Psychological Interventions. There is a wide variety of empirically supported
psychological interventions that are effective in treating GAD. Some of these are discussed
below.
Mindfulness meditation. Mindfulness is a therapy that involves “bringing one’s complete
attention to the present experience on a moment-to-moment basis” and “paying attention in a
particular way: on purpose, in the present moment, and nonjudgmentally” (Baer, 2003). This
directing of attention is developed through meditation, with an intentional self-regulation of
attention created by attending to internal experiences occurring in the present, such as bodily
sensations, thoughts, and emotions, while also focusing on the environment and paying attention
to stimuli, such as sights and sounds (Baer, 2003). A key part of practicing mindfulness is non-
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judgmentally accepting what is occurring in the present, and not evaluating them as positive or
negative, and instead, accepting perceptions, cognitions, and emotions or sensations as they are
experienced in the moment (Baer, 2003). It has been well documented that practicing
mindfulness can reduce symptoms of anxiety and improve quality of life (Baer, 2003).
There are several theories as to why mindfulness meditation may reduce anxiety
symptoms. For example, one argues that the exposure aspect of mindfulness allows individuals
with anxiety to maintain nonjudgmental observation of their anxiety symptoms, without trying to
avoid them, which could lead to reduction in their emotional response to such symptoms (Baer,
2003). This increase in awareness and nonreactivity has been found to be a mediator in the
relationship between anxiety decreases and practicing mindfulness (Hoge et al., 2015).
Mindfulness also cultivates cognitive change through the nonjudgmental observation and
training of recognizing thoughts as “just thoughts” instead of necessarily being reality (Baer,
2003). Mindfulness may also promote self-management, as observing one’s thoughts and
reflecting on one’s emotions may increase one’s ability to recognize impulsive, maladaptive
behaviors (Baer, 2003). Mindfulness meditation, like diaphragmatic breathing, promotes
abdominal breathing which induces relaxation as well (Chen et al., 2017). Furthermore,
mindfulness has been shown to increase parasympathetic influences on heart rate in individuals
with high generalized anxiety symptoms (Mankus et al., 2013). Finally, mindfulness meditation
promotes acceptance of one’s experiences and may encourage individuals to not try and avoid
their symptoms through maladaptive coping mechanisms such as drug or alcohol abuse, instead
accepting that they occasionally will experience symptoms of anxiety and can observe them
nonjudgmentally as they pass (Baer, 2003). Studies suggest that GAD may be characterized by
an inflexibility in response style and practicing mindfulness may improve their cognitive
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flexibility (Lee & Orsillo, 2014). Patients with anxiety disorders also seem to value the addition
of mindfulness techniques into treatment. One study found in a 3-year follow-up to a
mindfulness based stress reduction program that participants rated the program as a 7 or higher
on a scale of 1-10 assessing the importance of the program in their life and 89% of participants
reported the program had “lasting value” for them (Baer, 2003).
Behavioral strategies. Another common approach to treating GAD is through behavioral
approaches, which focus on adapting one’s maladaptive avoidance behaviors. The primary
symptom target here is avoidance, an important factor in the etiology of GAD.
Behavioral exposure. Exposure based treatments are known to be the most effective type
of treatment for anxiety disorders (McIntosh & Crino, 2013). This is because the avoidance
factor involved in worrying helps the person avoid feeling the emotional distress related to the
possibility of future negative events occurring, instead worrying about minor matters to lessen
internal distress (McIntosh & Crino, 2013). This cognitive avoidance is addressed by using
worry exposure, in which the client is prompted to imaginally expose themselves to their most
feared outcome for a prolonged period, as well as giving them response-prevention strategies to
help neutralize this image (McIntosh & Crino, 2013). This forced habituation to the feared image
allows the client to address the arousal that comes from the feared image and change the
meaning of the feared situation (McIntosh & Crino, 2013). Worry exposure has little research on
its effectiveness alone on symptoms of GAD, as it is usually combined with typical CBT
(McIntosh & Crino, 2013). However, McIntosh and Crino (2013) found that direct imaginal
exposure alone lead to an average decrease in worry of 37% and this reduction was maintained at
a follow-up. Furthermore, all participants in the direct imaginal exposure condition demonstrated
worry levels post-treatment that were in the subclinical GAD range (McIntosh & Crino, 2013).
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Hebert and Dugas (2019) note that a key risk factor in the development of GAD is
intolerance of uncertainty (IU) and that behavioral experiments can be used to treat this
component. These behavioral experiments would target uncertainty within negative beliefs and
show participants disconfirmatory information about previously held maladaptive beliefs (Hebert
& Dugas, 2019). Furthermore, behavioral experiences can help create neutral or positive beliefs
about uncertainty, while also facilitating fear response extinction via new inhibitory learning
(Hebert & Dugas, 2019). It has been demonstrated that IU-focused treatment produces a
significant decrease in GAD symptomatology and treatment progress was maintained for most
participants at a six-month follow-up (Hebert & Dugas, 2019).
Visualization. Some therapies for GAD utilize imagery visualization strategies. Such
strategies are taught in session and can be utilized by clients outside of the session. Guided
imagery is used to help patients focus on mental imagery and scenes that evoke a feeling of
relaxation for them (Mizrahi et al., 2012). This is a mind-body technique which helps the patient
actively control their attention (Jing, Wu, Liu, Wu, & Miao, 2011). By focusing their attention
on an imagined, relaxing scene, patients are disrupting stressful thoughts and images and
replacing them with more adaptive, positive ones (Mizrahi et al., 2012). Jing et al. (2011) found
that airplane pilots who used guided imagery prior to centrifuge training had reduced anxiety,
reduced heart rate, and decreased sympathetic nervous system activity.
Cognitive control strategies. In addition to physical and behavioral interventions for
GAD, cognitive control strategies have been proven effective for reducing GAD
symptomatology.
Cognitive Behavioral Therapy (CBT). CBT is the most empirically supported treatment
for GAD (Stefan, Cristea, Szentagotai Tatar, & David, 2019). Within CBT there is a wide variety
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of theoretical approaches to treatment and Stefan et al. (2019) evaluated the effectiveness of the
three most common types of CBT used to treat GAD: Cognitive Therapy/Borkovec’s treatment
package (CT/BTP), Rational Emotive Behavior Therapy (REBT), and Acceptance and
Commitment Therapy/Acceptance-based behavioral therapy (ACT/ABBT). All three of these
forms of CBT are based around the idea of modifying dysfunctional thoughts through cognitive
change (Stefan et al., 2019). CT/BTP focuses on modifying “cold” dysfunctional thoughts such
as “they criticize me”, while REBT focuses on modifying “hot” dysfunctional thoughts such as
“they should not criticize me and it is awful if they do” (Stefan et al., 2019). ACT, however, does
not attempt to modify the contents of dysfunctional thoughts specifically, instead changing the
individual’s relationship with the thoughts by neutralizing them (Stefan et al., 2019). Stefan et al.
(2019) stated that CBT that focuses on dysfunctional automatic thoughts instead of core beliefs
because the dysfunctional automatic negative thoughts are more related to anxiety symptoms.
Results comparing these three types of CBT showed no significant difference between the three
models in terms of outcomes regarding GAD (Stefan et al., 2019). REBT, ACT, and CT/BTP
were all proven effective in significant reduction of anxiety symptoms (Stefan et al., 2019).
Although CBT is widely considered an effective treatment for GAD, only about 50% of patients
reach high levels of functioning after treatment (Stefan et al., 2019), thus it is important that
clinicians utilize a holistic approach, involving other coping skills like diaphragmatic breathing
and meditation to achieve high levels of functioning.
Virtual Reality Treatment
VR is defined as a “technological interface that allows users to experience computergenerated environments within a controlled setting” (Maples-Keller, Bunnell, Kim, & Rothbaum,
2017). This is created by using head-mounted displays (HMDs) to engage the individual’s senses
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and promote interaction with the environment (Maples-Keller et al., 2017). Over the last three
decades, VR has been shown to be an effective therapy used to treat specific anxieties, PTSD,
and other anxious disorders compared to wait list controls (Pallavicini, Algeri, Repetto, Gorini &
Riva, 2009; Carl et al., 2019; Valmaggia, Latif, Kempton & Rus-Calafell, 2016; McCann et al.,
2014). The prices of VR systems have decreased significantly over the last ten years, with
mobile VR sets costing only $600 (Maples-Keller et al., 2017). Consumer VR sets often cost
more than $10,000 in the past (Lindner et al., 2019). Thus, feasibility of incorporating VRT into
traditional treatment settings has increased significantly in the last decade. Research supports the
viability of using low-cost consumer VR technology to conduct effective exposure therapy in
both traditional treatment sessions and in self-led, at home sessions (Lindner et al., 2019).
VR induces a sense of presence and can immerse the patient into their feared
environment (Maples-Keller et al., 2017). Many treatments for anxiety disorders involve patients
being able to stay in their feared situation until both their subjective and physiological fears
decline (Diemer, Mühlberger, Pauli & Zwanzger, 2014). Thus, therapeutic change may only
occur when psychophysiological fear structures are altered with corrective information (Diemer
et al., 2014). Diemer et al.’s (2014) meta-analysis of studies utilizing VR exposure therapy
demonstrated that VR exposure can evoke the psychophysiological arousal needed to alter fear
responses. Chirico and Gaggioli (2019) found that VR has comparable effects to experiencing a
real environment, with similar results regarding sense of physical presence and engagement,
positive and negative affect, and discrete emotional states (anger, awe, amusement, disgust, fear,
pride, sadness, and joy).
While the first studies began with treating acrophobia through exposure to high heights, a
significant variety of other environments have been created to treat a wide variety of feared

VIRTUAL REALITY THERAPY FOR GAD

33

situations (Maples-Keller et al., 2017). Meta-analyses even indicate a small effect size
supporting VR exposures for anxiety disorders over in vivo exposures, as well as a “powerful”
real-life impact and good long-term maintenance of results (Maples-Keller et al., 2017). Metaanalyses also indicate that in vivo exposure therapy is not significantly more effective than VR
exposure therapy (Powers & Emmelkamp, 2008).
Typical exposure therapy involves the person imagining their specific feared stimuli, and
it is entirely dependent on the patient to do so effectively, while VR eliminates potential barriers
patients may have in visualization (Maples-Keller et al., 2017). Furthermore, actual in vivo
exposures can be costly (i.e., actually flying on a plane), or difficult to conduct (i.e., combat in a
war zone), as well as presenting concerns with confidentiality (Maples-Keller et al., 2017). VR
exposures allow the environment to be controlled, utilizing gradual exposure, pacing, as well as
repeated exposures (Maples-Keller et al., 2017). Further research indicates that patients are
satisfied with VR exposure and may find it more helpful than traditional approaches (MaplesKeller et al., 2017). Patients are more likely to participate in VR exposures than in vivo
exposures, as one study identified a 3% refusal rate for VR exposure and a 27% refusal rate for
in vivo exposure (Maples-Keller et al., 2017). More research demonstrates that VR may address
barriers to treatment, with one study reporting that 19% of people who said they would be
unwilling to talk to a counselor in person would be willing to use VR approaches instead for
mental health care (Maples-Keller et al., 2017).
VR was first used to treat specific phobias, and there is a wealth of research that supports
its’ effectiveness in decreasing fears related to flying, heights, animals, needles, or blood
(Maples-Keller et al., 2017). Multiple randomized controlled studies about VR exposure on
specific phobias show symptom reduction and behavioral change through decreased avoidance
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(Maples-Keller et al., 2017). There is also support of VR exposure of social anxiety disorder
(SAD) demonstrating decreased anxieties after gradual exposure to VR social environments
(Maples-Keller et al., 2017). Similarly, VR exposure has been shown to be effective in treating
panic disorder and agoraphobia but putting the patients in situations that commonly elicit panic
or agoraphobia (Maples-Keller et al., 2017). VR for panic disorder and agoraphobia has been
shown to be advantageous in treatment response and less time required to complete treatment
(Maples-Keller et al., 2017).
VR exposure in the treatment of PTSD has been well researched and well supported with
medium-to-large effect sizes, with significant declines in PTSD symptoms after treatment with
VR (Maples-Keller et al., 2017). One study that had 10 participants complete VR treatment
resulted in 7 out of the 10 participants no longer meeting the diagnostic criteria for PTSD
anymore following treatment (Maples-Keller et al., 2017). Another study of veterans with PTSD
demonstrated that after six sessions of VR exposure therapy not only were PTSD symptoms
improved, but cortisol reactivity was reduced and maintained 12 months posttreatment (MaplesKeller et al., 2017). Moreover, VR prolonged exposure therapy has been found effective in
treating PTSD in active-duty soldiers who were deployed to Iraq or Afghanistan (Reger et al.,
2016).
Treatment of obsessive-compulsive disorder (OCD) utilizing VR has not yet been studied
in a randomized controlled study, however, some studies have demonstrated that VR can induce
anxiety in patients with OCD (Maples-Keller et al., 2017). Individuals with OCD often have a
variety of obsessions that may be difficult to create in a VR environment so unified treatment for
large groups is difficult to test, however, more research on treating OCD with VR is warranted
given its relation to other anxiety disorders (Maples-Keller et al., 2017).
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VR may also be used in the treatment of other mental disorders that do not fall under the
anxiety disorders category. For example, VR has shown promising results in treating
schizophrenia by having patients practice social skills and learn to cope with social distress
associated with delusional beliefs (Maples-Keller et al., 2017). It appears VR may have value in
addressing the isolation factor of schizophrenia by providing social skills training and
interactivity, as well as teaching assertiveness and understanding nonverbal social cues (MaplesKeller et al., 2017). Furthermore, Pot-Kolder and colleagues (2018) found that utilizing a VRCBT approach in adjunct to treatment-as-usual significantly reduced paranoid ideation and
anxiety in patients with psychotic disorders, further supporting the utilization of VR for this
population. Moreover, Fornells-Ambrojo et al. (2008) demonstrated that brief VR treatments are
safe for individuals with psychosis and are a good way to expose them to social situations that
may induce paranoia.
There is also significant research supporting VR’s utilization in the experience of acute
and chronic pain, as it facilitates a distraction from pain and VR has been demonstrated to be
more effective than other distraction techniques such as music and TV with headphones
(Maples-Keller et al., 2017). Multiple studies have demonstrated that VR used to decrease pain
significantly reduced the time spent thinking about pain and pain severity, as well as fMRI data
that shows reduced activity in brain regions that process sensory and emotional pain, thus
offering both subjective and objective evidence that VR can help in pain reduction (MaplesKeller et al., 2017).
There is also significant research on VRT in treating addiction by conditioning the
patient’s reactivity to drug or alcohol related cues in their environments, which is a key factor in
preventing relapse (Maples-Keller et al., 2017). Using VR based craving exposures patients can
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face their drug or alcohol related cues in a safe therapeutic environment, and this method is
effective in inducing the same physiological arousal, subjective craving, and impulse to use as
real-world triggers (Maples-Keller et al., 2017). There is even evidence for VR treatment in other
types of addictions, such as gambling, as VR casino environments were shown to induce the
same psychophysiological arousal and cravings in those addicted to gambling (Maples-Keller et
al., 2017).
VR’s effectiveness has also been studied in varying forms of eating pathology. For
example, VR can be used to explore body-image distortions as well as use exposure to food
triggers to identify and challenge triggers in the recovery process (Maples-Keller et al., 2017).
Other studies have demonstrated that VRT is effective in improving body awareness in
individuals with obesity and binge-eating disorders (Maples-Keller et al., 2017). Another
controlled study of 28 obese patients randomly assigned participants to VRT or CBT and found
that the VRT group demonstrated significantly higher improvements in body satisfaction, anxiety
level, and problematic eating (Maples-Keller et al., 2017).
VRT has also been investigated regarding its usefulness in treating concerns commonly
associated with Autism Spectrum Disorder, such as difficulties with communication, emotion
regulation, and theory of mind (Maples-Keller et al., 2017). There is preliminary evidence that
VR can be helpful in improving such areas of concern, however, results are not yet significant
given small sample sizes (Maples-Keller et al., 2017). Moreover, there is some research that
suggests VR technology has the potential to increase empathic abilities in humans, an important
social skill (Schoeller et al., 2019).
Cybersickness is the most common side effect associated with using immersive VRT
(Calogiuri et al. 2018). Pot-Kolder, Veling, Counotte and van der Gaag (2018) found five
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common symptoms of cybersickness including: general discomfort, fatigue, headache, difficulty
concentrating, and fullness of head. Other symptoms can include vomiting, nausea,
lightheadedness, vertigo, sweating, hot flashes, increased salivation, drowsiness and changes in
facial pallor (Dennison, Wisti & D'Zmura, 2016; Bouchard, St-Jacques, Renaud, & Wiederhold,
2009; Sharples, Cobb, Moody, & Wilson, 2008). Furthermore, oculomotor symptoms including
eyestrain and blurred vision may occur (Pot-Kolder et al., 2018).
These symptoms have been shown to last from minutes to up to five hours after VR
exposure, however, improvements in VR technology may decrease the occurrence of such
symptoms (Dennison et al., 2016). Such improvements include minimizing lag between head
movement and visual display updates, as well as reducing the weight of head mounted displays
(Dennison et al., 2016). Other research suggests that reducing sensory mismatch can reduce
symptoms of cybersickness as well as increase feelings of “being there” (Weech, Kenny, &
Barnett-Cowan, 2019). Furthermore, by increasing intuitiveness of interaction and navigation of
the technology also lead to higher presence and lower cybersickness (Weech at al., 2019).
Additionally, individuals with gaming experience demonstrate less cybersickness and higher
presence (Weech et al., 2019).
A common theory about cybersickness is the sensory conflict theory, in which cyber
sickness is believed to be caused by conflicting signals being received by both the visual and
vestibular systems (Calogiuri et al. 2018). Another common theory of cybersickness is the
postural instability theory which theorizes that long periods of time without postural control
causes cybersickness (Calogiuri et al. 2018). Others posit that motion sickness is a key factor in
cybersickness, with varying theories on the reasons for this including the body’s adaptive
response to a noxious stimulus, while others argue it prolonged postural instability that causes
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motion sickness (Dennison et al., 2016). Dennison et al. (2016) found that physiological
reactions such as changes in stomach activity, blinking behavior, and breathing are predictors of
cybersickness and argue that these signals demonstrate the mismatch between real and virtual
cues activate the autonomic nervous system.
Pot-Kolder et al. (2018) found that common cybersickness symptoms, specifically nausea
and disorientation, are better explained by anxiety symptoms than by cybersickness alone. Thus,
when VR helps decline symptoms of anxiety, it is hypothesized that the cybersickness symptoms
of nausea and disorientation will decrease after repetitive use of the VRT (Pot-Kolder et al.,
2018). Despite the concerns with cybersickness and VR side effects, research has demonstrated
that there are no reasons to be concerned with health and safety of the client within 24 hours of
the VR session (Bouchard et al., 2009). However, side effects should still be closely monitored
because most participants experience slight side effects (Bouchard et al., 2009). It is important to
note that Bouchard et al. (2009) found that some side effects found in participants were strong
even before the immersion in the VRT.
Virtual Reality and GAD Treatment
Research has demonstrated the effectiveness of using VRT in the treatment of other
mental illnesses, and there is promising research for using VRT in the treatment of GAD as well.
Given GAD’s wide variety of worries that are individualized to the patient exposure therapy for
GAD is difficult to conduct, thus VR based treatment for GAD could focus on facilitating a
visual guide for breathing exercises and for practicing relaxation or mindfulness approaches, as
this project suggests (Maples-Keller et al., 20187). VR can be used to facilitate relaxation in
anxious participants by providing relaxing images that also induce a sense of presence
(Pallavicini et al., 2009). VR can be used to help patients practice and master relaxation, while
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also providing more vivid and “real” experiences than most subjects can induce by imagination
and memory alone (Pallavicini et al., 2009). Pallavicini et al. (2009) conducted a study that
supports the possibility of using VR to treat GAD with a significant decrease in symptoms, as
well as 91% of patients reporting they were satisfied with the VR treatment.
Patients with GAD demonstrate significantly lower amounts of mindfulness and
mindfulness is a common treatment approach as described above (Navarro-Haro et al., 2019).
Because worrying can take up one’s attentional resources, patients with GAD may have reduced
ability to sustain attention during mindfulness-based treatments (Navarro-Haro et al., 2019).
Thus, the distraction of worry may impact treatment outcomes VR can function as a visual guide
for practicing mindfulness by giving patients the feeling of “being there” in the present moment
(Navarro-Haro et al., 2019). Navarro-Haro et al. (2019) tested this theory and found that after
treatment, VR patients showed significant decreases anxiety, as well as increased emotion
regulation with improvements in confusion, impulsivity, and interoceptive awareness.
Furthermore, it was found that patients who were assigned to the VR group were more
likely to adhere to the intervention than patients in the standard mindfulness intervention alone
(Navarro-Haro et al., 2019). This supports my theory that VR can engage patients and increase
treatment adherence and retention. The Navarro-Haro et al. (2019) study also only utilized VR
10 minutes before or for 10 minutes after traditional mindfulness sessions, which supports this
project’s structure of adding VR component to treatment adjunct to treatment-as-usual.
Nature Therapy and VRT
It has been well documented that coming into contact with nature can enhance positive
affect (Barnes et al., 2019), psychological well-being, and health (Schutte, Bhullar, Stilinović &
Richardson, 2017). For example, when a group of nonclinical participants were randomly
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assigned to go into nature every day for two weeks, they experienced significantly higher
positive affect compared to the control group that was assigned to experience human-built
surroundings everyday instead (Schutte et al., 2017). Moreover, this study also included a
“business-as-usual” control group, and the nature assigned group still experienced significantly
more positive affect (Schutte et al., 2017). It is thought that evolution shaped humans to obtain
benefits from exposure to nature, both physical and psychologically (Schutte et al., 2017). Not
only has nature contact increased both hedonic (pleasure and comfort) and self-transcendent
(awe, gratitude, wonder, and sense of being part of something greater than yourself) emotions,
but research has also demonstrated that the length of contact with nature does not have impact on
the amount of improvement, suggesting short intervals of nature exposure are beneficial to
psychological well-being (Neill, Gerard, & Arbuthnott, 2019). Neill et al. (2019) demonstrated
that improvements in emotions in university students after exposure to nature environments can
be obtained within five minutes.
Exposure to nature has also been documented to show benefit in clinical populations as
well (Schutte et al., 2017). Schutte et al. (2017) designed a study to evaluate the effectiveness of
using virtual natural environments on well-being and found that VR experience of natural
environments compared to VR experience of an urban environment led to higher levels of
positive affect. The effect size found in this study (r =.46) was larger than the effect sizes
previously found for environments simulated by film or photographs (r =.21) and was somewhat
larger than the effect size impact of actual environment (r =.37) (Schutte et al., 2017). These
results demonstrate promise in the utilization of VR based environments for positive impact on
psychological well-being (Schutte et al., 2017). Similarly, Chirico and Gaggioli (2019) found
that exposure to a VR nature environment decreased anger, sadness, and negative affect.
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VR exposure to nature can also provide nature exposure for individuals living in isolated
confined environments (Anderson et al., 2017). Being in nature provides restorativeness through
being away from routine mental concerns, interest-driven attention, and is supported by an
environment of substantial scope (Anderson et al., 2017). Since new VR technology provides
high degrees of scene immersion and presence, VR natural environments also have the ability to
evoke restorativeness (Anderson et al., 2017). VR natural scenes are not only superior to control
urban environments, which may prevent relaxation, but were also found to be superior to a
neutral indoor scene (Anderson et al., 2017). Electrodermal activity, which increase as stress is
induced, significantly decreased in the VR nature condition, and negative affect also decreased
significantly after the natural VR experience and not in the control experience (Anderson et al.,
2017).
VR natural scenes have not only been found to decrease stress and anxiety, as well as
improve mood when compared with urban environments, but coastal natural environments have
been significantly beneficial (Tanja-Dijkstra et al., 2018). Natural VR coastal environments also
demonstrated analgesic properties for pain management, providing more support for the
transferable nature exposure effects using VR (Tanja-Dijkstra et al., 2018). Such effects were
shown to not be due to distraction alone, as the effects were not found in a control group that was
exposed to urban environments, thus, again supporting the benefits of exposure to natural
environments (Tanja-Dijkstra et al., 2018). Furthermore, there is research that suggests that
adding nature sounds to a virtual natural environment can induce the same physiological stress
reduction, through parasympathetic nervous activation, just as a real nature environment would
(Annerstedt et al., 2013).
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Research has demonstrated that immersive natural environments may be hindered by
cybersickness caused by movement lag, poor postural control, and flatness (Calogiuri et al.
2018). Thus, future VR technology should focus on creating a holistic sensory experience with
better image quality and prompt for postural control to prevent cyber sickness (Calogiuri et al.,
2018).
Section III: Original Contribution to Practice
Methods
Participants. Participants will include students enrolled full-time at the university, who
are eligible to receive counseling center services, and who receive an elevated score on the
generalized anxiety scale on the CCAPS-62 (Locke et al., 2011). If the client meets these three
criteria, and the clinician determines that the client meets criteria for GAD, they may suggest
participation in this program as a part of their treatment plan. Students indicating any concerns
with psychotic symptoms, mania or hypomania, or substance abuse should not be included in the
program.
Technology equipment. There is a company called Limbix, which creates digital
therapies that can be utilized by mental health professionals. The Limbix VR Kit was “inspired
by over 300 peer reviewed studies that have shown VR can play a meaningful role in healthcare”
and was created with the help of mental health professionals (“Limbix,” n.d.). The Limbix VR
Kit is medical grade, wireless, and does not require internet. The VR kit comes with a VR
headset that is medical grade and can be sanitized with wipes, a tablet that connects to the VR
headset via Bluetooth, a docking station to charge, transport, and store the kit, as well as
complete access to their full VR immersive environment library. Per their website, these
environments allow patients to “visit remote locations and relax in tranquil nature environments
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while in authentic, virtual environments” (“Limbix,” n.d.). The VR headsets provide real-world
360-degree footage that is built from panoramic images and videos, rather than animated
graphics, which allows patients to more easily experience true “presence with visceral
sensations” (“Limbix,” n.d.). Although exposure therapy will not be utilized in the proposed
program, the Limbix VR kit also offers a unique way for therapists to gradually increase
exposure for patients with specific phobias and anxieties.
Virtual environments available currently include: driving exposure, depression, trauma,
anxiety, addiction and teenage depression psychoeducational films, public speaking,
claustrophobia, fear of needles, agoraphobia, bars & drinks, world traveler, teleporter where you
can visit any address around the world on Google Street View, as well as various positive games.
Their website states that coming soon they will also include job interview environments, social
anxiety, fear of heights, school anxiety, behavioral activation, and guided imagery (“Limbix,”
n.d.). This proposed program would utilize the tree mindfulness environment, in which you
“observe an environment and engage in tasks that encourage mindful growth and exploration to
transition the scene from winter to spring” (“Limbix,” n.d.). Focus meditation, in which you
“concentrate on single objects in a dark environment for focus meditation” (“Limbix,” n.d.).
Nature environments, in which you can “relax in tranquil, outdoor environments while optionally
listening to guided meditation tracks” (“Limbix,” n.d.). Breathing exercises in which you
“practice diaphragmatic breathing and learn how to reduce feelings of anxiety” (“Limbix,” n.d.).
The Limbix VR Kit that is readily available for anyone to purchase costs $1,999 and
includes the VR headset, tablet, docking station, content library, online training, and email
support (“Limbix,” n.d.). There is a custom research project headset that is offered at a custom
price which includes the VR headset, tablet, docking station, content library, and research
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support including: custom data logging, study design support, and grant collaborations
(“Limbix,” n.d.). While the VR equipment should be readily available for students to use with a
scheduled appointment Monday – Friday, students may also have the option of purchasing their
own, relatively cheap mobile-VR set so that they may continue to use this intervention after their
12-session limit has been reached. Mobile based VR may also be helpful in allowing patients to
utilize the technology in real time whenever they need to become relaxed in their time away from
the office presence (Pallavicini et al., 2009).
Clinician Requirements. Clinicians must be master’s or Doctoral level practitioners who
are well versed in treating GAD and its accompanying concerns. Clinicians must be licensed in
their state of practice or receive adequate supervision required to practice without a license. They
should have experience in teaching clients how to effectively utilize diaphragmatic breathing and
mindfulness meditation to reduce symptoms of anxiety. They should also be well versed in the
research behind these treatments and be able to provide a rationale for treatment and
psychoeducate the client on why the treatment is a worthy endeavor. Clinicians must also be able
to provide rationale for utilizing VR in treatment as well as demonstrate the credibility of
incorporating VR into treatment (Maples-Keller et al., 2017). The clinicians should also be
familiar with the Limbix VR Kit and be able to set up and operate it. It is recommended that the
clinicians familiarize themselves with the environments offered and utilize them to become
familiar with how they operate and what clients can expect. In-depth training and practice with
the equipment is necessary before administration. Clinicians should also be well educated on the
potential risks and side effects of using VR equipment, such as cybersickness.
Psychological Outcome Measures. The CCAPS-62 (Locke et al., 2011) and the
CCAPS-34 (Locke et al., 2012) will be used to track progress on generalized anxiety scores. The
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GAD-7 (Spitzer, et al., 2006) will also be used to track progress. The CCAPS-34 (Locke et al.,
2012) will be administered at the beginning of every session to track progress week-by-week.
The CCAPS-62 (Locke et al., 2011) will be administered at the beginning of session 1 and at the
beginning of session 11. The GAD-7 (Spitzer, et al., 2006) will be administered at the end of
session 1 and at the end of session 11 to evaluate progress. Students will be emailed to complete
a follow-up CCAPS-34 (Locke et al., 2012) and GAD-7 (Spitzer, et al., 2006) at 1-3- and 6months post-treatment to see if progress is maintained.
Proposed Outline. The program will consist of 11 sessions of VRT within a counseling
center setting. The counseling center will have a room or use an existing computer room to rent
out the space for appointments using the equipment. As most Counseling Center’s run on a timelimited brief therapy model, this adjunct to therapy will be beneficial in providing the most
comprehensive care in a time limited setting.
Initial contact. The initial contact, not included in the session total, will be used to
interview the client to determine presenting concerns and suitability for VRT treatment. In this
session the client will fill out counseling center paperwork, take the CCAPS-62 (Locke et al.,
2011), and speak with a clinician about their concerns. By the end of the first session the
clinician should determine if the client is appropriate for VRT treatment for GAD and educate
them on the program if they meet criteria.
Session 1. The second contact will include treatment as usual, plus an additional 30minute psychoeducational introduction to utilizing the VR equipment. The clinician will educate
the client on how to best utilize the technology, as well as discussing the benefits of utilizing it.
Clinicians should emphasize that repeated use of the equipment leads to better outcomes. Once a
client has been trained on how to use the equipment, the clinician will mark in their electronic
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file that the student may schedule times to utilize the VR equipment on their own. Clients will be
encouraged so schedule 30-minute sessions with the VR equipment coinciding with their regular
treatment times. Clients may also utilize the equipment outside of their normal treatment times.
Clients can check out the VR equipment from the administration at the front desk in the
counseling center, provided they leave their student ID at the front desk while they use the
equipment. The clinician should check in with the client at their normal session to monitor how
often they are utilizing the VR equipment as well as answer any questions or concerns about it. It
is important that the clinician assess the client’s perceived value of the VR adjunct to treatment.
Program Evaluation
The participants will be emailed and asked to complete a follow up CCAPS-34 (Locke et
al., 2012) and GAD-7 (Spitzer, et al., 2006) at one month, three months, and 6 months following
treatment to assess prolonged effects of treatment. Participants will also be asked to complete a
posttreatment survey designed specifically to assess satisfaction with treatment and perceived
benefits. To assess the effectiveness of adding the VRT alongside typical GAD treatment, the
counseling center could randomly assign half of the students who meet criteria for GAD to the
VRT experimental group, while the other half provide a control measure by only receiving
treatment per usual. Statistical analyses should be conducted to determine if the effect size
between the groups are significant.
Proposed Budget
The budget will consist of $2,000 allocation for the VR equipment. If the counseling
center has the funding and willingness to expand, the purchase of four sets at $2,000 each would
need to allocate $8,000 for cost. The program will be advertised through the school’s social
media department free of cost. The program will also be advertised by the clinician through word
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of mouth whenever they encounter a student who meets the proposed criteria to participate in the
program.
Conclusion
As contemporary technologies have become a central part in modern life, it is important
that treatments adjust accordingly and integrate new technologies into existing treatment
modalities. Increasing access to VRT has allowed this technology to become an effective
treatment delivery method for various mental disorders, including GAD. The benefits of utilizing
a cost-effective, evidence-based treatment in counseling centers are demonstrated in this
manuscript.
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